RYPNX
Price
$15.95
Change
+$0.02 (+0.13%)
Updated
Nov 19 closing price
Net Assets
1.02B
VISVX
Price
$48.35
Change
-$0.09 (-0.19%)
Updated
Nov 19 closing price
Net Assets
58.35B
Interact to see
Advertisement

RYPNX vs VISVX

Header iconRYPNX vs VISVX Comparison
Open Charts RYPNX vs VISVXBanner chart's image
Royce Small-Cap Opportunity Invmt
Price$15.95
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets1.02B
Vanguard Small Cap Value Index I
Price$48.35
Change-$0.09 (-0.19%)
VolumeN/A
Net Assets58.35B
RYPNX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
RYPNX vs. VISVX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYPNX is a Hold and VISVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 58.3B vs. RYPNX (1.02B). VISVX pays higher dividends than RYPNX: VISVX (1.90) vs RYPNX (0.00). RYPNX was incepted earlier than VISVX: RYPNX (29 years) vs VISVX (28 years). RYPNX (1.22) is less costly to investors than VISVX (0.19). RYPNX is a more actively managed with annual turnover of: 35.00 vs. VISVX (16.00). RYPNX has a lower initial minimum investment than VISVX: RYPNX (2000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : -1.93 vs. RYPNX (-4.20). VISVX return over 5 years is better than : 55.92 vs. RYPNX (13.93).
RYPNXVISVXRYPNX / VISVX
Total Expense Ratio1.220.19642%
Annual Report Gross Expense Ratio1.220.19642%
Fund Existence29 years28 years-
Gain YTD2.9702.266131%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets1.02B58.3B2%
Annual Yield % from dividends0.001.90-
Returns for 1 year-4.20-1.93218%
Returns for 3 years10.3824.3043%
Returns for 5 years13.9355.9225%
Returns for 10 years30.95104.0930%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELMD25.210.69
+2.81%
Electromed
MLTX13.550.15
+1.12%
MoonLake Immunotherapeutics
MPLX53.320.45
+0.85%
Mplx LP
VRAR1.04N/A
N/A
Glimpse Group (The)
NAMS38.62-0.29
-0.75%
NewAmsterdam Pharma Company NV